274 related articles for article (PubMed ID: 24145083)
1. Disparate effects of anti-TNF-α therapies on measures of disease activity and mediators of endothelial damage in ankylosing spondylitis.
Korkosz M; Gąsowski J; Surdacki A; Leszczyński P; Pawlak-Buś K; Jeka S; Siedlar M; Grodzicki T
Pharmacol Rep; 2013; 65(4):891-7. PubMed ID: 24145083
[TBL] [Abstract][Full Text] [Related]
2. Assessment of serum asymmetric dimethylarginine levels and left ventricular diastolic function in patients with ankylosing spondylitis.
Inci U; Yildiz A; Batmaz I; Tekbas E
Int J Rheum Dis; 2017 Feb; 20(2):238-244. PubMed ID: 26012572
[TBL] [Abstract][Full Text] [Related]
3. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
McLeod C; Bagust A; Boland A; Dagenais P; Dickson R; Dundar Y; Hill RA; Jones A; Mujica Mota R; Walley T
Health Technol Assess; 2007 Aug; 11(28):1-158, iii-iv. PubMed ID: 17651658
[TBL] [Abstract][Full Text] [Related]
4. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal anti-TNF antibodies can elevate hemoglobin level in patients with ankylosing spondylitis.
Bes C; Yazici A; Soy M
Rheumatol Int; 2013 Jun; 33(6):1415-8. PubMed ID: 23143665
[TBL] [Abstract][Full Text] [Related]
6. Decrease of asymmetric dimethyl arginine after anti-TNF therapy in patients with rheumatoid arthritis.
Spinelli FR; Di Franco M; Metere A; Conti F; Iannuccelli C; Agati L; Valesini G
Drug Dev Res; 2014 Nov; 75 Suppl 1():S67-9. PubMed ID: 25381982
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.
de Vries MK; van Eijk IC; van der Horst-Bruinsma IE; Peters MJ; Nurmohamed MT; Dijkmans BA; Hazenberg BP; Wolbink GJ
Arthritis Rheum; 2009 Nov; 61(11):1484-90. PubMed ID: 19877087
[TBL] [Abstract][Full Text] [Related]
8. Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study.
Arends S; Brouwer E; van der Veer E; Groen H; Leijsma MK; Houtman PM; Th A Jansen TL; Kallenberg CG; Spoorenberg A
Arthritis Res Ther; 2011 Jun; 13(3):R94. PubMed ID: 21689401
[TBL] [Abstract][Full Text] [Related]
9. The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness.
Angel K; Provan SA; Mowinckel P; Seljeflot I; Kvien TK; Atar D
Atherosclerosis; 2012 Nov; 225(1):160-5. PubMed ID: 23014354
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: effect of TNFalpha antagonist therapy.
Wendling D; Cedoz JP; Racadot E
Joint Bone Spine; 2008 Oct; 75(5):559-62. PubMed ID: 18674944
[TBL] [Abstract][Full Text] [Related]
11. TNFα antagonist therapy does not increase the Epstein-Barr virus burden in patients with rheumatoid arthritis or ankylosing spondylitis.
Couderc M; Payet S; Henquell C; Dubost JJ; Soubrier M
Joint Bone Spine; 2010 Oct; 77(5):414-7. PubMed ID: 20542718
[TBL] [Abstract][Full Text] [Related]
12. Effects of 14 weeks of TNF alpha blockade treatment on lipid profile in ankylosing spondylitis.
Mathieu S; Dubost JJ; Tournadre A; Malochet-Guinamand S; Ristori JM; Soubrier M
Joint Bone Spine; 2010 Jan; 77(1):50-2. PubMed ID: 20022785
[TBL] [Abstract][Full Text] [Related]
13. Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy.
Kwon SR; Lim MJ; Suh CH; Park SG; Hong YS; Yoon BY; Kim HA; Choi HJ; Park W
Rheumatol Int; 2012 Aug; 32(8):2523-7. PubMed ID: 21833531
[TBL] [Abstract][Full Text] [Related]
14. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
Maksymowych WP; Poole AR; Hiebert L; Webb A; Ionescu M; Lobanok T; King L; Davis JC
J Rheumatol; 2005 Oct; 32(10):1911-7. PubMed ID: 16206346
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of etanercept for treating ankylosing spondylitis].
Liang LQ; Zhan ZP; Ye YJ; Fu D; Xu HS; Yang XY
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1349-51. PubMed ID: 18753057
[TBL] [Abstract][Full Text] [Related]
16. TNF-alpha inhibitors for ankylosing spondylitis.
Maxwell LJ; Zochling J; Boonen A; Singh JA; Veras MM; Tanjong Ghogomu E; Benkhalti Jandu M; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD005468. PubMed ID: 25887212
[TBL] [Abstract][Full Text] [Related]
17. Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register.
Lord PA; Farragher TM; Lunt M; Watson KD; Symmons DP; Hyrich KL;
Rheumatology (Oxford); 2010 Mar; 49(3):563-70. PubMed ID: 20032223
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of the Bath Ankylosing Spondylitis Indices of disease activity (BASDAI), functional status (BASFI) and overall well-being (BAS-G) in anti-tumour necrosis factor-treated spondyloarthropathy patients.
Madsen OR; Rytter A; Hansen LB; Suetta C; Egsmose C
Clin Rheumatol; 2010 Aug; 29(8):849-54. PubMed ID: 20306214
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and treatment responses of patients satisfying the BSR guidelines for anti-TNF in ankylosing spondylitis.
Gadsby K; Deighton C
Rheumatology (Oxford); 2007 Mar; 46(3):439-41. PubMed ID: 17255137
[TBL] [Abstract][Full Text] [Related]
20. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
